Novel herpesviruses have been described recently. These include human herpesviruses 6, 7 and 8 (HHV-6, -7, -8). HHV-6 has at least two strain groups, variants A and B. The B strains are predominant in the West and can account for over 97 % of infections in infants. In contrast, the A strains are rare and the few well-characterized isolates have been from adult African AIDS patients. It is not clear whether the HHV-6 variant A strains are AIDSrelated and/or whether they can also be acquired as childhood infections and may reactivate later during adulthood. What contribution geographical variation plays has yet to be assessed. HHV-8 has been associated with AIDS-related epidemic Kaposi's sarcoma (KS), but has also been identified in endemic KS. In regions of Africa where KS is
Introduction
Morbidity and mortality in AIDS are often associated with reactivating herpesvirus infections. Herpesviruses are usually common childhood infections which remain latent and can act as opportunists during immunosuppression to reactivate to cause disease ; they may also be sexually transmitted. Due to their widespread nature and ability to reactivate there are speculations on possible interactions between these viruses and human immunodeficiency virus (HIV) affecting the progression to AIDS. The contribution of two recently described human herpesviruses, human herpesviruses 6 (HHV-6) and 8 , has yet to be fully assessed. HHV-6, like HIV, has a cellular tropism for CD4 + T lymphocytes where it is cytolytic, and was first isolated from AIDS patients. It was later defined mainly by its primary infection, as the causative Author for correspondence : U. A. Gompels.
Fax j44 171 637 4314. e-mail ugompels!hgmp.mrc.ac.uk endemic, the onset of AIDS has led to increased prevalence of KS. In this report, we examine in Zambia, an AIDS epidemic and KS endemic region, infection with these novel herpesviruses during infancy. In blood samples from human immunodeficiency virus-negative infants with first febrile episode, both semi-quantitative PCR and sequence analyses were used to identify HHV-8 in 8 % and HHV-6 in 30 %, with 44 % of these variant A ; in childhood endemic KS biopsies HHV-8 was detected in 100 % and HHV-6 in none. The high viral-DNA loads in the infant blood samples were consistent with viraemia. This is the first demonstration that HHV-6 variant A and HHV-8 may be acquired as common childhood infections. agent of exanthem subitum, a skin rash with fever (as reviewed in Gompels et al., 1995) . Later studies showed that serious, sometimes fatal, complications can arise such as pneumonitis, encephalitis, bone marrow suppression, hepatitis and disseminated infections (Asano et al., 1990 (Asano et al., , 1992 Prezioso et al., 1992 ; Knox et al., 1995 a, b ; Knox & Carrigan, 1996 b) , and that these can also be observed during virus reactivation in the adult (Cone et al., 1993 a ; Drobyski et al., 1993 ; Gompels et al., 1994 ; McCullers et al., 1995) . More recent studies show that HHV-6 primary infection is a common and serious paediatric complication accounting for high fever and up to 20 % of visits to emergency wards (Hall et al., 1994) where respiratory and gastrointestinal symptoms as well as seizures were more commonly observed than the initial defining rash of exanthem subitum (Portolani et al., 1993 ; Hall et al., 1994 ; Ward & Gray, 1994) . HHV-6 is probably the first childhood infection acquired as maternal immunity decreases, usually between 6 to 9 months, and by adulthood up to 100 % of the population may be seropositive (Ward et al., 1993) . In fact, in one study of in African infants HHV-6 variant A and HHV-8 in African infants children under the age of 3, HHV-6 was the major virus infection in febrile children, accounting for 40 % of hospitalizations (Portolani et al., 1993) . In AIDS patients disseminated infections have been observed with anecdotal reports of fatalities due to pneumonitis and encephalitis (Knox et al., 1995 a, b) .
HHV-6 is related to human cytomegalovirus (HCMV). It has a 159 kb genome encoding over 100 genes and has strain variation which can be grouped as variants A and B (Gompels et al., 1993 (Gompels et al., , 1995 . These groups may be due to geographical variation or may be associated with different pathologies, in particular its relationship to HIV\AIDS. In the USA, the B variant strains predominate particularly in children (Dewhurst et al., 1993) whereas the A strains have mostly been isolated from adult AIDS patients from parts of Africa (Downing et al., 1987 ; Tedder et al., 1987) . Thus, can A strains be acquired as a childhood infection or are they acquired by another route as an adult, such as sexual transmission, and are they AIDS related ? Do the different strains have different virulence, in particular in their relationship to AIDS ? Recent evidence in the USA shows variant A in the lymph nodes and plasma of AIDS patients, indicative of an active infection (Secchiero et al., 1995 ; . In the earlier stages of HIV infection both strain groups appear to be associated with lymphadenopathy and can be detected in these biopsies, although in PBMC during progression to AIDS the level of virus detected by PCR decreases, presumably due to loss of the CD4 + target cells caused by HIV and possibly also by HHV-6 reactivation itself (Fairfax et al., 1994 ; Sieczkowski et al., 1995 ; . Does strain variation account for differences in pathology in AIDS patients ? Of all the herpesviruses which may reactivate during AIDS, only HHV-6 has a cellular tropism similar to that of HIV such that it may directly interact with this virus. HHV-6 permissively infects CD4 + T lymphocytes where infection results in cell death by cell fusion (Tedder et al., 1987 ; Takahashi et al., 1989) . Evidence for a site of latency has also been defined within cells of the monocytic\ macrophage lineage or within bone marrow (Kondo et al., 1991 ; Drobyski et al., 1993) .
These speculations for a relationship between HHV-6 variant A and HIV have recently been eclipsed by attention to another possible AIDS associated herpesvirus. In 1994, DNA sequences of a newly defined herpesvirus, HHV-8, were identified in Kaposi's sarcoma (KS) of AIDS patients (Chang et al., 1994) . HHV-8 has been subsequently identified in HIV negative endemic forms of KS (Huang et al., 1995 ; Chuck et al., 1996 ; Luppi et al., 1996) . Sequence analyses of 20n7 kb and analyses of growth in B cell lines show that this agent is most closely related to other oncogenic herpesviruses, Epstein-Barr virus (EBV) and herpesvirus saimiri, with a total genome of over 200 kb (Cesarman et al., 1995 ; Mesri et al., 1996 ; Renne et al., 1996 ; Moore et al., 1996) . Some reports suggest that this virus may be acquired as a sexually transmitted disease in AIDS patients (Chang et al., 1994 ; Moore & Chang, 1995 ; Whitby et al., 1995) , while other reports show that this virus may be identified in healthy adults or in HIV negative lymphoproliferation (Bigoni et al., 1996 ; Luppi et al., 1996) . Therefore, a key question for this virus as well as for HHV-6 variant A is whether first infection is common during childhood like many other herpesviruses such as varicella-zoster virus or herpes simplex virus type 1 (HSV-1), or whether they are being contracted primarily as a sexually transmitted disease in adults as with herpes simplex virus type 2 (HSV-2). Is KS associated with a de novo HHV-8 infection or with increased virus load during virus reactivation in immunodeficient settings. Is it a cofactor or passenger in this disease ? In Zambia there is epidemic AIDS and endemic KS. Since the advent of AIDS, KS incidence has increased, consistent with a reactivating virus infection (Chintu et al., 1995) . In order to assess transmission of AIDS related HHV-6 variant A and HHV-8 we examined by PCR blood from HIV negative infants who were experiencing their first hospitalized fever, as well as in childhood endemic KS. This would also set up a baseline study to correlate with pathology in the HIV positive patients.
Methods
Patient selection and sample collection. Between March 1995 and October 1995, samples were collected from infants and children seen at the paediatric department of the University Teaching Hospital (UTH), Lusaka, Zambia. The UTH is a 2000-bed hospital which acts as a referral facility for the whole of Zambia. Most of the patients, however, come from within Lusaka, as UTH is the largest general hospital in Lusaka and serves an estimated population of around a million people. Basic clinical details were collected for these infants and children (age, sex, clinical symptoms\signs and duration of symptoms) after which an appropriate sample was collected. Prior ethics approval for the study had been obtained from the combined UTH\UNZA ethics committee. Informed consent was further obtained from the parent or guardian of each infant or child before any sample was collected.
Sample preparation
1. Infants presenting to hospital with first fever. Venous whole blood (2n4 ml) was collected, DNA extracted using ' Genomix whole blood ', according to the manufacturer's (Genomix Talent Sri) instructions and then re-suspended in a final volume of 30 µl of TE buffer (10 mM Tris, 0n1 mM EDTA, pH 8). This extraction method involves precipitation with a cationic detergent which forms specific DNA micellar complexes. Extraction efficiencies are greater than 90 % and are uncontaminated by RNA.
2. Infant with ' atypical measles '. Peripheral blood leukocytes (PBL) were separated by Ficoll-Hypaque centrifugation from 3 ml of blood, then treated with Proteinase K-SDS ; DNA was extracted with phenolchloroform, precipitated with ethanol and resuspended in 20 µl of TE as previously described (Gompels et al., 1993) .
3. Children with Kaposi's sarcoma. Childhood KS biopsy tissue routinely submitted for histology at UTH was used in this study. The biopsy consisted of lymph node and overlying skin and had been stored frozen at k70 mC. The samples were thawed, placed in PBS on ice, then minced and digested overnight with Proteinase K-SDS. DNA was purified by extraction with phenol-chloroform followed by ethanol precipitation, and the DNA resuspended in 30 µl of TE buffer.
F. C. Kasolo, E. Mpabalwani and U. A. Gompels F. C. Kasolo, E. Mpabalwani and U. A. Gompels HIV-1/2 screening. All sera from infants and children had been screened as part of routine diagnostics at the UTH virology laboratory for antibodies to HIV-1 and HIV-2 using a commercially available ELISA kit (Wellcozyme ELISA VK 57, Murex Diagnostics). Only infants and children testing negative for HIV antibodies were included in this study.
PCR amplification of DNA. All samples were screened for cellular DNA by using a primer set that amplifies a 110 bp fragment of the human prolactin gene. Human prolactin gene amplification was used as an internal control for the integrity of samples for PCR as well as a guideline for the estimation of copy numbers of cells and virus. All samples reported here tested positive for human prolactin gene amplification with varied visual intensity corresponding to estimated copy numbers of 10 to 100 copies. Sample DNA was amplified with three primer sets : HHV-6 [210 bp variable glycoprotein fragment of U47 gene primer pair (Gompels et al., 1993 (Gompels et al., , 1995 ], HHV-8\KSHV [233 bp fragment of minor capsid protein gene primer pair KS330 (Chang et al., 1994) ] and human [110 bp prolactin gene fragment primer pair (Amadou, 1995) ]. PCR was carried out under standard conditions with of Taq polymerase (Promega), and buffer containing 10 mM Tris pH 8n5, 50 mM KCl, 1n5 mM MgCl # , 0n01 % gelatin, 0n5 % Tween 20 and 0n2 % Triton X-100, 1 µM primers, 200 µM dNTPs, in a total volume of 19 µl with 1 µl of template (corresponding to 7 to 190 cells and related dilutions ; see Tables 2, 3 and 4) or control DNA. The thermocycling procedure was denaturation at 94 mC for 4 min then 50 cycles at 94 mC for 30 s, annealing at 53 mC for 30 s, and extension at 72 mC for 120 s ; 50 cycles had increased sensitivity over 30 or 35 with these reaction conditions. Each run contained two negative controls (water and uninfected JJhan cellular DNA), and a positive control (HHV-6 variant A U1102 strain and a previously amplified and sequenced HHV-8\KSHV positive sample, Zam13). The PCR products were resolved and detected visually by 0n8 % agarose gel electrophoresis with ethidium bromide staining ; confirmation was by Southern hybridization using $#P-end-labelled internal primers or by nucleotide sequencing.
DNA quantification.
Spectrophotometry was done at 260 and 280 nm in order to determine the concentration of all DNA samples and to calculate the actual number of cells per sample via genome equivalents and eventually the number of cells sampled per µl. The method of DNA preparation (Genomix) using detergent specific extraction results in pure DNA uncontaminated by RNA with an average A #'! \A #)! ratio of 1n8. Using the molecular mass of the cellular genome, the numbers of cells were calculated for each sample. Estimation of HHV-6 and HHV-8 DNA in the samples was done by comparison with dilution standards of known cell copy numbers of JJhan cellular DNA and HHV-6 (strain U1102) as well as comparison with the intensity of amplification of a cellular gene of known copy number, prolactin. Dilution standards were set up by performing PCR on 10-fold dilutions (10 −" to 10 −) ) of known copy numbers of HHV-6 and JJhan cellular DNA. These were compared with dilutions of sample DNA. The sensitivity of the PCR method was determined by noting the dilution at which the PCR signal was no longer visible and relating this to the number of copies present at that dilution (amount of DNA in dilution). A fragment of the human prolactin gene was also amplified in a separate reaction for each sample to serve as an internal control, as the actual copy number had been calculated from the input DNA, and the intensity of this signal was compared with the PCR of viral DNA. The sensitivity of each primer set was comparable, averaging 10 copies. In all cases, the number of copies calculated by comparison with dilution standards and the number calculated by comparison with the internal cellular control agreed within 10-to 100-fold. This included a method control of comparing copies of each sample cellular DNA estimated from comparisons with JJhan dilution standards with that of the actual input genome equivalents calculated from the sample DNA concentration.
DNA purification, cloning and sequencing. The HHV-6 DNA was gel purified, cloned into M13, and multiple independent clones from at least two independent reactions were sequenced. Gel purified HHV-6 DNA PCR products were digested with BamHI [the HHV-6 primer set introduced BamHI sites (Gompels et al., 1993) ], separated by electrophoresis in an agarose gel, the relevant DNA fragments excised, purified by phenol extraction\ethanol precipitation, then ligated with BamHIdigested, phosphatase-treated M13 mp18 vector DNA, and transformed into E. coli JM109. Sequencing reactions were carried out on single stranded M13 clones using dideoxynucleotide chain termination as previously described (Gompels et al., 1993 (Gompels et al., , 1995 . The sequence of the 210 bp HHV-6 fragment was derived using the M13 universal primer (Promega). The HHV-8 233 bp PCR products were purified directly after the reaction using a Qiagen kit and nucleotide sequence derived using a cycle sequencing protocol (Promega) with Taq polymerase. The radiolabelled DNA molecules were separated on 6 % polyacrylamide-8 M urea Tris-borate-buffered gels which were fixed in 10 % methanol, 10 % acetic acid, vacuum dried and visualized by exposure to X-ray film.
Results

Semi-quantitative DNA amplification assay
For detection of virus sequences and estimation of relative virus load, a semi-quantitative PCR amplification assay was established. This involved comparison of dilutions of amplified samples with dilutions of known standards. In addition, every reaction was accompanied by negative controls for reagents (water control) and for contamination by using a cellular DNA control. Estimates calculated by this method were also compared to estimates made by comparing intensities of an internal control using a separate reaction with primers for a cellular gene, human prolactin. As the DNA concentration was measured by spectrophotometry for each sample the actual cellular copy number could be calculated and compared with that of viral targets estimated by dilutions. In each case, estimates from PCR amplifications and dilution compared within 2 logs to the actual copy number. Each sample analysed was subjected to three independent amplifications, HHV-6, HHV-8 and human genes. Thus, for each sample the copy number was calculated in comparison both with dilutions of standards and with comparisons of intensities of the internal control cellular gene where the actual copy number was already calculated. For these purposes the primer set sensitivities should be similar and those used here were 10 copies.
HHV-6 and HHV-8 in infants with ' first fever '
The patient samples were collected from infants with their ' first fever ' admitted to the University Teaching Hospital in Lusaka, Zambia. This group was chosen because evidence shows that HHV-6 is usually first acquired between 6 to 9 months as the maternal immunity decreases. Furthermore, recent studies have shown that of admissions of patients under IEJ HHV-6 variant A and HHV-8 in African infants HHV-6 variant A and HHV-8 in African infants Fig 1) ; , not determined. † WBC number from Table 1 ; 30 µl DNA from 2n4 ml whole blood, 1 µl DNA per PCR reaction. ‡ Copy numbers determined in comparison with standards in serial dilutions, plus by comparison with internal standard of PCR to human prolactin gene (see text). § These samples are also HHV-8 positive (see Table 3 ). R In this 12-month-old female patient, DNA was extracted from purified lymphocytes ; the patient was segregated suspected of measles on the basis of a fever and maculopapular rash but diagnosed as having ' atypical measles ' in that no measles virus was isolated.
the age of 2 to the emergency ward for febrile illness in the USA, up to 20 % were a result of primary HHV-6 infection (Ward et al., 1993 ; Hall et al., 1994) . Thus, this group was ideally suited to asking the question of whether HHV-6 variant A is present in infants in Africa. Furthermore, with the exception of HSV-2, the other human herpesviruses are also primarily acquired during childhood. Thus, this group would also be suitable to test the hypothesis of transmission of HHV-8. Blood samples were taken as part of routine diagnostics and all used in this study were negative for HIV by serology (Wellcozyme assay). DNA was extracted from whole blood of 53 patients who ranged in age from 2 to 12 months. The DNA yield indicated that the white blood cell (WBC) numbers ranged from 413 to 1362 per ml of blood, which is only slightly lower than the normal range seen at UTH for healthy Zambian infants (between 1000 to 2000 per ml) (Haematology Department, UTH, Lusaka, Zambia). The total cell count would be 3 logs higher due to erythrocytes, which are not included in the cell number calculations as they lack nuclei. With DNA extraction efficiencies of over 90 %, the lower WBC counts calculated for the febrile patient group are indicative of a general leukopenia in at least some of the infants, as would be expected depending on the cause of their fevers and reasons for hospitilization. DNA equivalent to between 33 to 109 cells was sampled in each PCR reaction for HHV-6, HHV-8 and human genes. Such low cell numbers were used for two reasons. First, because of the small sample size from the infants, and secondly to avoid any detection of ' latent ' DNA, which would require greater cell numbers (see below). In Table 1 the results are summarized for the infants positive for virus sequences. Of the 53 infants analysed, 16 (30 %) were positive for HHV-6 and 4 (8 %) were positive for HHV-8. The findings for HHV-6 in Zambia are in agreement with those found for a similar infant group in the USA (Hall et al., 1994) , but the results for HHV-8 are the first reported in this age group. The levels detected for both viruses were between 300 to 18 000 copies per cell (Tables 2 and 3 ). This contrasts with levels detected in normal adults, which average only 1 copy per 10& to 10' cells, presumably representing latent infection (Cone et al., 1993 b ; Cuende et al., 1994 ; Bigoni et al., 1996) . Thus, in order to detect latent adult DNA between 10& to 10' cells would need to be sampled to detect one genome copy of DNA (Cone et al., 1993 b ; Cuende et al., 1994) . Here we have sampled only between 10 to 10# cells, thus avoiding detecting latent DNA, but nonetheless with these cell numbers have detected between 10% to 10' copies. Extrapolating to the IFB HHV-6 variant A and HHV-8 in African infants HHV-6 variant A and HHV-8 in African infants * Samples positive for both HHV-6 and HHV-8 (see Table 2 ) ; Zam13 sampled 3 months later was HHV-8 positive only, but with no symptoms. † RTI, respiratory tract infection. ‡ Quantification and sampling as for Table 2 (see text) .
results for infant's cells shown in Table 2 , if between 10& to 10' of their cells were examined this would equal between 10* to 10"# copies of viral DNA or at least 9 logs higher than seen in latently infected adults for either HHV-6 or HHV-8 (see last section of Results for further discussion on HHV-8 quantification and KS). Two additional points should be noted. First, these samples assayed were from whole blood so virus DNA detected may also represent cell-free virus as would be observed in a viraemia. Second, such high levels of virus DNA per cellular genome equivalent are produced in permissive lytic infections in vitro for both HSV and HHV-6 where 10% copies per cell can be measured by Southern blotting. Thus, detection at or near these levels in vivo is consistent with an acute infection. Given the age of the patient group, all under 1 year, and that this appeared to be their first childhood infection, this would be consistent with a primary infection with these viruses. For HHV-8, this is the first demonstration of infection within this age group and arguably represents primary infection within childhood similar to that observed for other human herpesviruses.
Strain variation and identification of HHV-6 variant A in infants
To date, only HHV-6 variant B has been unambiguously identified in HHV-6 primary viraemias in childhood (Dewhurst et al., 1993) , but these studies centred in the USA may reflect geographical variation as has been observed for other viruses (Gompels et al., 1995) . However, in a related study a single infant with variant A infection has been identified and analyses of the mother's PBMCs showed variant A also, suggesting mother-child transmission for both variants A and B (Van Loon et al., 1995) . Thus, there may be strong geographical variation Fig. 1 . Branching order in a phylogenetic tree for nucleotide sequence (A) and encoded amino acid sequence (B) of the U47 gene fragment from Zambian HHV-6 strains (Zam) compared with laboratory reference strains of variant B (Z29 and KF) or variant A (U1102, AJ and GS). The amino acid sequence of Zam025 is identical to U1102, while Zam13, Zam18B and Zam15B are identical to Z29. Similarity scores calculated from exact matches between each two aligned sequences produced a matrix of scores giving a dendrogram by applying the UPGMA method, used then to progressively align sequences to give branching orders [ClustalV, HigginsSharp algorithm (Higgins & Sharp, 1989) as implemented on a PowerMac 6200 computer]. The percentage similarities shown reflect divergence from a common branchpoint and are not simple two-by-two alignments. There is a high ratio of non-synonymous to synonymous changes at this locus as observed in increased amino acid variation.
for this virus given the early age and its likely maternal transmission. In order to determine the strain group in the Zambian infants, HHV-6 positive samples were also analysed for strain variation in a genome region described previously which segregates between the strain groups. Nine samples were amplified in this region, cloned, sequenced and analysed by multiple alignments followed by phylogenetic analyses (Fig. 1) . Each sample was cloned and sequenced twice from at least two independent amplifications in order to control for possible PCR errors. The results show that there is up to 5 % variation between the strains as indicated by both nucleotide and amino acid sequence analyses. Further, variant A is present in 44 % of these samples, which is completely different from the USA profile of less than 3 %. The variation observed is like a mosaic with incremental, overlapping change observed as has been shown for HCMV. For example, in the nucleotide sequence there is up to 2 % variation within strain groups and between 2 to 5 % variation between strain groups in the region analysed, while for the amino acid sequence up to 6 % variation within and 4 to 8 % variation between groups. 
IFC
Clinical diagnosis in HHV-6 and HHV-8 positive infants
The main symptoms other than fever accompanying detection of HHV-6 were respiratory symptoms (19 %) and rash (12 %) (Tables 1 and 2 ). In the HHV-6 positive samples the average cell count was 688 per ml, which would be consistent with a leukopenia. Although the numbers are low these complications are similar to that found for infants in the USA (Hall et al., 1994) . In one instance, the symptoms of an HHV-6 positive infant were described as ' atypical measles ', but no measles virus was identified or isolated, which suggests that in certain cases there may be misdiagnosis between exanthem subitum and measles, as has been observed in the UK (Tait et al., 1996) . In much of Africa, however, exanthem subitum is not a regular diagnosis ; thus, the cases of HHV-6 fever plus rash in Table 2 for both A and B variants may represent the first identification and raises the possibility that symptomatic diagnosis of measles may include exanthem subitum. Of the HHV-8 positive samples (Tables 1 and 3) , two were also positive for HHV-6, but in these cases the only observed symptom was fever, which could be due to either virus. However, the other two samples were only positive for HHV-8. These also had relatively low cell numbers (average 431 per ml) as well as respiratory symptoms, findings which will be interesting to follow in larger data sets and in comparison with primary infections in childhood AIDS patients. Of note, all HHV-8 positive were male, consistent with the male bias seen in KS, albeit at a lower ratio in childhood KS (Chintu et al., 1995 ; Ziegler & KatongoleMbidde, 1996) . These patients were further investigated to determine the HIV status of the mother (which in all cases was seronegative) as well as to follow up how long the DNA levels would persist. Two infants were followed up 3 months later and blood samples taken : in one the HHV-6 DNA could no longer be detected, with HHV-8 still positive ; the other was positive for HHV-8 only, and the DNA level persisted after the respiratory symptoms and fever had cleared.
Childhood KS in Zambia
HHV-8 has been identified in endemic KS including childhood KS, but has not been examined within Zambia (Chintu et al., 1995 ; Chuck et al., 1996) . Thus, as infection with this agent has been indicated from the above studies in infants, it was important to determine whether HHV-8 is also linked with childhood KS in Zambia. DNA was extracted from frozen biopsy material that had been taken previously from HIV negative KS patients and stored for routine diagnostics. DNA equivalent to between 32 to 190 cells was sampled for PCR amplification using the same primer sets as described above. Again, cell numbers were limited to rule out the affects of latently infected blood DNA. Using this sample size in the absence of any form of quantitative PCR, any positive PCR result, even if it only represents a single copy of HHV-8 DNA, is already 3 logs higher than in latently infected blood. In Table  4 we show that 100 % of biopsies analysed were positive for HHV-8 sequences but were negative for HHV-6. Using the semi-quantitative PCR technique, the copy numbers ranged from 526 to 25 641 per cell in the frozen samples. The semiquantitative PCR for HHV-6 had an internal error estimated as IFD a factor of 10 (see Methods). For HHV-8 there is an additional factor of 10, in that the sensitivity of the HHV-8 primer pair could be 10-fold more than that for human prolactin (10 copies) and this was not assessed versus infected cell DNA. This results in a combined error of 10#, which could reduce the copy number to between 5 and 256 per cell. Nonetheless, this is still 6 to 8 logs higher than has been observed at the periphery in blood of apparently healthy, presumably latently infected individuals (Bigoni et al., 1996) . This could be consistent with an active infection at or in tissue associated with these lesions or may represent high copy numbers of latent DNA within all or part of the sample. At the end of the work presented here, HHV-8 genes cloned from this material for expression studies were used in control dilution studies and still showed copy numbers within this range in the remaining KS DNA samples. It is possible that childhood KS has higher copy numbers than adult KS and presents more often with a concurrent viraemia, but direct quantification of adult KS is lacking and comparisons have not yet been made.
Children with KS presented as two broad clinical pictures : 60 % had predominately generalized skin lesions as the main clinical symptom while 40 % had lymphadenopathy. Those presenting with lymphadenopathy were mostly younger while those presenting a predominantly skin picture were relatively older ; overall there was a male bias (80 %) (Table 4) . Thus, in Zambia, a KS endemic region, HHV-8 can be detected within febrile infants (8 %) and childhood KS (92 %). All HHV-8 samples detected by PCR, first fever and KS, were sequenced directly and showed variation from the Chang & Moore strain similar to that observed for other African endemic KS analysed, but too low (1 to 2 %) to do cluster analyses.
Discussion
The main finding from our studies is that two herpesviruses which have been linked with AIDS and found mainly in adults are here identified in infants at high levels. This indicates that HHV-6 variant A and HHV-8 may be transmitted as childhood infections like most of the other human herpesviruses. This does not rule out contracting additional strains later after the primary infection, which again has been shown for other herpesviruses [for example, most recently with HHV-6 (Van Loon et al., 1995) ], but it does show that it is possible to contract these infections at an early age and that primary infection may reactivate later during immunosuppressive settings such as AIDS. The infection may be initiated in utero, during childbirth or during infancy, and any of these scenarios gives the same result that an infection can be present from an early age and may reactivate later. Thus, it is still possible that HHV-6 variant A is AIDS linked, but, like variant B, it can initiate as a childhood infection. However, the A and B variant strains show sufficient variation such that they may be associated with different pathologies. Thus, in an area such as Zambia where there is a high incidence of childhood AIDS and where up to 37 % of pregnant women in some regions are HIV positive (Nkowane, 1991) , which may result in impaired maternal immunity in their infants, it is of great interest to compare pathologies associated with strain variants in these immunosuppressed conditions where control of both primary and reactivated infections will be impaired.
As with HHV-6 variant A, we have detected the presence of HHV-8 DNA in infants also, demonstrating that primary infection can occur early and may be followed by reactivation in the adult during immunosuppression such as AIDS. Such an interpretation may also be consistent with studies that have linked HHV-8 positive HIV patients as having risk of developing KS (Moore & Chang, 1995 ; Whitby et al., 1995) . These authors have interpreted their findings as de novo infections. Another interpretation is that they are measuring virus reactivation. Given that the cell number sampled from blood in one of these studies was 10% (Moore & Chang, 1995) they would have to sample about 100 times more cells to detect latent DNA, as described by Bigoni et al. (1996) , and consistent with levels of latent DNA for other blood-borne herpesviruses such as HHV-6 and EBV (Cone et al., 1993 b ; Cuende et al., 1994) . This low cell sampling is also reflected in the low detection of EBV in healthy blood donors used as a control by Whitby et al. (1995) . Another interpretation of the current findings is that in a KS endemic country, HHV-8 infection is unusually prevalent where transmission patterns may differ, resulting in infant infection and a higher risk of developing KS. This may be so, but it is inconsistent with the finding of a similar proportion (6 %) of HHV-8 DNA in HIV negative adults in the non-endemic KS population of Italy (Bigoni et al., 1996) . Furthermore, from the Zambian infant samples analysed the incidence of HHV-8 is at least 8 % ; this is far higher than the incidence of KS within the Zambian population, which comprises 18 per million children (Chintu et al., 1995) . This incidence has increased with the advent of AIDS, including childhood KS. Thus, taken together, the identification of HHV-8 in infants with first fever and in childhood KS of HIV negative patients suggests that HHV-8 infection may be a risk factor for KS dependent on virus load rather than a causal de novo sexually transmitted agent, as has been suggested from studies of adult HIV positive and AIDS patients. Thus, sexual transmission of HHV-8 in the adult requires adequately sensitive evaluation for virus reactivation as well as new infection. As the distinction between the range of endemic HIV negative and AIDS epidemic KS continues to blur, the use of KS as an AIDS defining illness may be less useful in KS endemic regions of Africa (Matondo, 1995) .
Finally, the data presented raise the interesting question as to whether early HHV-6 variant A infection may be a predisposing factor for the development of HHV-8 associated, endemic KS. For example, HIV infection is a predisposing factor for development of epidemic KS, which may involve immunosuppression or direct interactions. Zambia is the first population identified with common childhood primary in-F. C. Kasolo, E. Mpabalwani and U. A. Gompels F. C. Kasolo, E. Mpabalwani and U. A. Gompels fection with HHV-6 variant A. HHV-6 itself has been characterized as an immunodeficiency agent, and infection or reactivation can lead to leukopenia during primary infection as well as suppression of bone marrow growth due to reactivation in these cell types, and may underlie other pathologies (Drobyski et al., 1993 ; Gompels et al., 1994 ; Hall et al., 1994 ; Knox et al., 1995 b ; Knox & Carrigan, 1996 a, b) . Infection of immune cells in vitro can lead to impairment aside from cytolysis such as inhibition of PBMC proliferative response, suppression of macrophage maturation or monocyte respiratory burst, inhibition of bone marrow progenitor cell differentiation, inhibition of IL-2 synthesis, and aberrant expression of CD3 and CD4 (Flamand et al., 1995 ; Furlini et al., 1996) , as reviewed (Gompels et al., 1995) . The virulence of strains may differ and there is some suggestion of this in studies of HIV interactions that showed variant A strains in lymph nodes and sera, indicative of active infections in AIDS patients (Secchiero et al., 1995 ; . Thus, HHV-6 variant A in blood\lymph nodes may be important to monitor as a risk factor in association with HHV-8 in the KS lesion for endemic and possibly epidemic KS. There may also be strain differences in HHV-8 that are important for the development of endemic KS, although this is not supported by analyses of the small genome region studied here. This is currently being assessed together with interactions of these viruses with HIV\AIDS. The African countries with endemic KS are also at the focus of HIV infection and the AIDS epidemic (Nkowane, 1991) . Thus, our data also identify an important issue concerning whether the occurrence of childhood infections with HHV-6 variant A and HHV-8 affect pathology in AIDS epidemic regions.
